Cytomegalovirus Anterior Uveitis and Endotheliitis: Searching for the Therapeutic Holy Grail
- PMID: 40390666
- DOI: 10.1111/ceo.14546
Cytomegalovirus Anterior Uveitis and Endotheliitis: Searching for the Therapeutic Holy Grail
References
-
- P. A. Tookey, A. E. Ades, and C. S. Peckham, “Cytomegalovirus Prevalence in Pregnant Women: The Influence of Parity,” Archives of Disease in Childhood 67 (1992): 779–783.
-
- N. S. Chan, S. P. Chee, L. Caspers, and B. Bodaghi, “Clinical Features of CMV‐Associated Anterior Uveitis,” Ocular Immunology and Inflammation 26, no. 1 (2018): 107–115.
-
- R. La Distia Nora, I. Putera, Y. D. Mayasari, et al., “Clinical Characteristics and Treatment Outcomes of Cytomegalovirus Anterior Uveitis and Endotheliitis: A Systematic Review and Meta‐Analysis,” Survey of Ophthalmology 67, no. 4 (2022): 1014–1030.
-
- Z. X. Thng, I. Putera, I. Testi, et al., “The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 2‐Global Current Practice Patterns for the Management of Cytomegalovirus Anterior Uveitis,” Eye (London, England) 38, no. 1 (2024): 68–75.
-
- S. P. Chee and A. Jap, “Cytomegalovirus Anterior Uveitis: Outcome of Treatment,” British Journal of Ophthalmology 94, no. 12 (2010): 1648–1652.